280 related articles for article (PubMed ID: 26162359)
1. CD4 T-cell cytokine correlates of diagnostic tests for latent tuberculous infection in HIV-1-infected subjects.
Van Epps P; Sridaran S; Aung H; Wilson BM; Burant CJ; Nserko M; Mayanja-Kizza H; Betts MR; Toossi Z; Canaday DH
Int J Tuberc Lung Dis; 2015 Aug; 19(8):927-35. PubMed ID: 26162359
[TBL] [Abstract][Full Text] [Related]
2. T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis.
Nemeth J; Winkler HM; Karlhofer F; Selenko-Gebauer N; Graninger W; Winkler S
Eur Cytokine Netw; 2010 Mar; 21(1):34-9. PubMed ID: 20146988
[TBL] [Abstract][Full Text] [Related]
3. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
[TBL] [Abstract][Full Text] [Related]
4. Measurement of phenotype and absolute number of circulating heparin-binding hemagglutinin, ESAT-6 and CFP-10, and purified protein derivative antigen-specific CD4 T cells can discriminate active from latent tuberculosis infection.
Hutchinson P; Barkham TM; Tang W; Kemeny DM; Chee CB; Wang YT
Clin Vaccine Immunol; 2015 Feb; 22(2):200-12. PubMed ID: 25520147
[TBL] [Abstract][Full Text] [Related]
5. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
[TBL] [Abstract][Full Text] [Related]
6. Quantitative IFN-γ and IL-2 Response Associated with Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women.
Mathad JS; Bhosale R; Balasubramanian U; Kanade S; Mave V; Suryavanshi N; Gupte N; Joshi S; Chandanwale A; Dupnik KM; Kulkarni V; Deshpande P; Fitzgerald DW; Gupta A
Am J Respir Crit Care Med; 2016 Jun; 193(12):1421-8. PubMed ID: 26765255
[TBL] [Abstract][Full Text] [Related]
7. Mycobacteria-Specific Mono- and Polyfunctional CD4+ T Cell Profiles in Children With Latent and Active Tuberculosis: A Prospective Proof-of-Concept Study.
Tebruegge M; Ritz N; Donath S; Dutta B; Forbes B; Clifford V; Zufferey C; De Rose R; Robins-Browne RM; Hanekom W; Graham SM; Connell T; Curtis N
Front Immunol; 2019; 10():431. PubMed ID: 31024518
[No Abstract] [Full Text] [Related]
8. The assessment of cytokines in Quantiferon supernatants for the diagnosis of latent TB infection in a tribal population of Melghat, India.
Bapat PR; Husain AA; Daginawala HF; Agrawal NP; Panchbhai MS; Satav AR; Taori GM; Kashyap RS
J Infect Public Health; 2015; 8(4):329-40. PubMed ID: 25824629
[TBL] [Abstract][Full Text] [Related]
9. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.
Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G;
Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of Tuberculin Skin Test (TST) and T-SPOT.TB Tests for Diagnosis of Latent Tuberculosis Infection (LTBI) in HIV-infected Patients].
Binay UD; Fincancı M; Fersan E; Karakeçili F
Mikrobiyol Bul; 2019 Oct; 53(4):388-400. PubMed ID: 31709936
[TBL] [Abstract][Full Text] [Related]
11. Added Value of Long-Term Cytokine Release Assays to Detect Mycobacterium tuberculosis Infection in HIV-Infected Subjects in Uganda.
Dirix V; Schepers K; Massinga-Loembe M; Worodria W; Colebunders R; Singh M; Locht C; Kestens L; Mascart F;
J Acquir Immune Defic Syndr; 2016 Jul; 72(3):344-52. PubMed ID: 27306506
[TBL] [Abstract][Full Text] [Related]
12. Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-α inhibitors.
Papay P; Primas C; Eser A; Novacek G; Winkler S; Frantal S; Angelberger S; Mikulits A; Dejaco C; Kazemi-Shirazi L; Vogelsang H; Reinisch W
Aliment Pharmacol Ther; 2012 Nov; 36(9):858-65. PubMed ID: 22978645
[TBL] [Abstract][Full Text] [Related]
13. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
[TBL] [Abstract][Full Text] [Related]
14. Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection.
Elzi L; Steffen I; Furrer H; Fehr J; Cavassini M; Hirschel B; Hoffmann M; Bernasconi E; Bassetti S; Battegay M
BMC Infect Dis; 2011 Nov; 11():319. PubMed ID: 22085801
[TBL] [Abstract][Full Text] [Related]
15. The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiological study.
Elliott AM; Hurst TJ; Balyeku MN; Quigley MA; Kaleebu P; French N; Biryahwaho B; Whitworth JA; Dockrell HM; Hayes RJ
Int J Tuberc Lung Dis; 1999 Mar; 3(3):239-47. PubMed ID: 10094326
[TBL] [Abstract][Full Text] [Related]
16. Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection.
Leidl L; Mayanja-Kizza H; Sotgiu G; Baseke J; Ernst M; Hirsch C; Goletti D; Toossi Z; Lange C
Eur Respir J; 2010 Mar; 35(3):619-26. PubMed ID: 19608590
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma release assay versus tuberculin skin test for latent tuberculosis infection among HIV patients in Brazil.
Kussen GM; Dalla-Costa LM; Rossoni A; Raboni SM
Braz J Infect Dis; 2016; 20(1):69-75. PubMed ID: 26706018
[TBL] [Abstract][Full Text] [Related]
18. Combined use of a TST and the T-SPOT®.TB assay for latent tuberculosis infection diagnosis before anti-TNF-α treatment.
Jung YJ; Lyu J; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee KH; Lee SD; Kim WS; Kim DS; Shim TS
Int J Tuberc Lung Dis; 2012 Oct; 16(10):1300-6. PubMed ID: 22863375
[TBL] [Abstract][Full Text] [Related]
19. The phenotypic distribution and functional profile of tuberculin-specific CD4 T-cells characterizes different stages of TB infection.
Streitz M; Fuhrmann S; Thomas D; Cheek E; Nomura L; Maecker H; Martus P; Aghaeepour N; Brinkman RR; Volk HD; Kern F
Cytometry B Clin Cytom; 2012 Nov; 82(6):360-8. PubMed ID: 22961735
[TBL] [Abstract][Full Text] [Related]
20. The association of smoking with IGRA and TST results in HIV-1-infected subjects.
Aichelburg MC; Mandorfer M; Tittes J; Breitenecker F; Reiberger T; Rieger A; Kohrgruber N
Int J Tuberc Lung Dis; 2014 Jun; 18(6):709-16. PubMed ID: 24903943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
